Oncology Cancer Drugs Market Insights Video

According to Cognitive Market Research, the global Oncology Cancer Drugs market size was USD 169548.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 8.00% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 67819.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 50864.46 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 38996.09 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.
• Latin America had a market share of more than 5% of the global revenue with a market size of USD 8477.41 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 3390.96 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.
• Chemotherapy held the highest Oncology Cancer Drugs market revenue share in 2024.